Psilocybin Therapy Retreat for Burned-Out Healthcare Workers
Treatments studied
Part of Mental health clinical trials.
This study tests whether psilocybin (a psychedelic compound) given during a guided retreat can help healthcare clinicians who have lost meaning in their work and are experiencing depression. Participants will attend preparation sessions and a multi-day retreat where they receive psilocybin in a supportive group setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You work as a healthcare clinician (doctor, nurse, nurse practitioner, or physician assistant) and are currently practicing
- You are between 25 and 70 years old
- You have felt that the deep meaning you once found in your work has faded over the past 5 years
- You have moderate symptoms of depression (confirmed by a screening questionnaire)
- You can commit to all preparation meetings and attend the full retreat without missing days
- You are willing to stop taking herbal supplements with mood-affecting properties (like St. John's Wort or 5-HTP) before the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.
This study tests whether psilocybin, given with professional therapy support, can help UCSD doctors who are feeling burned out. You would attend several clinic visits to receive the medicine and talk through your experiences.
This study tests a group therapy program that includes a psychedelic medicine for first responders struggling with conditions like depression, anxiety, or PTSD. It is a 12-week program with mostly remote sessions and two in-person visits.
This study tests whether psilocybin—a psychedelic compound—combined with group therapy can help people with depression. Participants receive guided psilocybin sessions at UCLA and attend group therapy to process the experience.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.